高血圧および心不全薬の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Hypertension and Heart Failure Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(DATA910T06615)・商品コード:DATA910T06615
・発行会社(調査会社):QYResearch
・発行日:2019年12月6日
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥405,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥608,400見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥811,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、高血圧および心不全薬の世界市場について調査・分析し、高血圧および心不全薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(利尿薬、ベータ遮断薬、エース阻害薬、アルファ遮断薬、その他)、用途別(男性用、女性用)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の高血圧および心不全薬市場動向
・主要企業別マーケットシェア
・高血圧および心不全薬の種類別市場規模2014-2019
(利尿薬、ベータ遮断薬、エース阻害薬、アルファ遮断薬、その他)
・高血圧および心不全薬の用途別市場規模2014-2019
(男性用、女性用)
・高血圧および心不全薬の北米市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬の中国市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬の日本国内市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬の東南アジア市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬のインド市場:主要企業・種類別/用途別市場規模
・高血圧および心不全薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Menarini Group、Johnson & Johnson、Lupin、Boehringer Ingelheim、Novartis、Merck & Co、AstraZeneca、Pfizer, Inc、Sanofi SA、Dr. Reddy's Laboratories、Daiichi Sankyo Company Limited)
・高血圧および心不全薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.In 2018, the global Hypertension and Heart Failure Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hypertension and Heart Failure Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypertension and Heart Failure Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Menarini Group
Johnson & Johnson
Lupin
Boehringer Ingelheim
Novartis
Merck & Co
AstraZeneca
Pfizer, Inc
Sanofi SA
Dr. Reddy’s Laboratories
Daiichi Sankyo Company Limited

Market segment by Type, the product can be split into
Diuretics
Beta Blockers
Ace Inhibitors
Alpha Blockers
Others

Market segment by Application, split into
Men
Women

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hypertension and Heart Failure Drugs status, future forecast, growth opportunity, key market and key players.
To present the Hypertension and Heart Failure Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hypertension and Heart Failure Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Diuretics
1.4.3 Beta Blockers
1.4.4 Ace Inhibitors
1.4.5 Alpha Blockers
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hypertension and Heart Failure Drugs Market Share by Application (2019-2025)
1.5.2 Men
1.5.3 Women
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hypertension and Heart Failure Drugs Market Size
2.2 Hypertension and Heart Failure Drugs Growth Trends by Regions
2.2.1 Hypertension and Heart Failure Drugs Market Size by Regions (2019-2025)
2.2.2 Hypertension and Heart Failure Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Hypertension and Heart Failure Drugs Market Size by by Players
3.1.1 Global Hypertension and Heart Failure Drugs Revenue by by Players (2014-2019)
3.1.2 Global Hypertension and Heart Failure Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Hypertension and Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Hypertension and Heart Failure Drugs Key Players Head office and Area Served
3.3 Key Players Hypertension and Heart Failure Drugs Product/Solution/Service
3.4 Date of Enter into Hypertension and Heart Failure Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hypertension and Heart Failure Drugs Market Size by Type (2014-2019)
4.2 Global Hypertension and Heart Failure Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Hypertension and Heart Failure Drugs Market Size (2014-2019)
5.2 Hypertension and Heart Failure Drugs Key Players in North America
5.3 North America Hypertension and Heart Failure Drugs Market Size by Type
5.4 North America Hypertension and Heart Failure Drugs Market Size by Application

6 Europe
6.1 Europe Hypertension and Heart Failure Drugs Market Size (2014-2019)
6.2 Hypertension and Heart Failure Drugs Key Players in Europe
6.3 Europe Hypertension and Heart Failure Drugs Market Size by Type
6.4 Europe Hypertension and Heart Failure Drugs Market Size by Application

7 China
7.1 China Hypertension and Heart Failure Drugs Market Size (2014-2019)
7.2 Hypertension and Heart Failure Drugs Key Players in China
7.3 China Hypertension and Heart Failure Drugs Market Size by Type
7.4 China Hypertension and Heart Failure Drugs Market Size by Application

8 Japan
8.1 Japan Hypertension and Heart Failure Drugs Market Size (2014-2019)
8.2 Hypertension and Heart Failure Drugs Key Players in Japan
8.3 Japan Hypertension and Heart Failure Drugs Market Size by Type
8.4 Japan Hypertension and Heart Failure Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hypertension and Heart Failure Drugs Market Size (2014-2019)
9.2 Hypertension and Heart Failure Drugs Key Players in Southeast Asia
9.3 Southeast Asia Hypertension and Heart Failure Drugs Market Size by Type
9.4 Southeast Asia Hypertension and Heart Failure Drugs Market Size by Application

10 India
10.1 India Hypertension and Heart Failure Drugs Market Size (2014-2019)
10.2 Hypertension and Heart Failure Drugs Key Players in India
10.3 India Hypertension and Heart Failure Drugs Market Size by Type
10.4 India Hypertension and Heart Failure Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Hypertension and Heart Failure Drugs Market Size (2014-2019)
11.2 Hypertension and Heart Failure Drugs Key Players in Central & South America
11.3 Central & South America Hypertension and Heart Failure Drugs Market Size by Type
11.4 Central & South America Hypertension and Heart Failure Drugs Market Size by Application

12 International Players Profiles
12.1 Menarini Group
12.1.1 Menarini Group Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypertension and Heart Failure Drugs Introduction
12.1.4 Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2014-2019))
12.1.5 Menarini Group Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypertension and Heart Failure Drugs Introduction
12.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Lupin
12.3.1 Lupin Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypertension and Heart Failure Drugs Introduction
12.3.4 Lupin Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.3.5 Lupin Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypertension and Heart Failure Drugs Introduction
12.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.4.5 Boehringer Ingelheim Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypertension and Heart Failure Drugs Introduction
12.5.4 Novartis Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Merck & Co
12.6.1 Merck & Co Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hypertension and Heart Failure Drugs Introduction
12.6.4 Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.6.5 Merck & Co Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hypertension and Heart Failure Drugs Introduction
12.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Pfizer, Inc
12.8.1 Pfizer, Inc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hypertension and Heart Failure Drugs Introduction
12.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.8.5 Pfizer, Inc Recent Development
12.9 Sanofi SA
12.9.1 Sanofi SA Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hypertension and Heart Failure Drugs Introduction
12.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.9.5 Sanofi SA Recent Development
12.10 Dr. Reddy’s Laboratories
12.10.1 Dr. Reddy’s Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hypertension and Heart Failure Drugs Introduction
12.10.4 Dr. Reddy’s Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
12.10.5 Dr. Reddy’s Laboratories Recent Development
12.11 Daiichi Sankyo Company Limited

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hypertension and Heart Failure Drugs Key Market Segments
Table Key Players Hypertension and Heart Failure Drugs Covered
Table Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Diuretics Figures
Table Key Players of Diuretics
Figuer Beta Blockers Figures
Table Key Players of Beta Blockers
Figuer Ace Inhibitors Figures
Table Key Players of Ace Inhibitors
Figuer Alpha Blockers Figures
Table Key Players of Alpha Blockers
Figuer Others Figures
Table Key Players of Others
Table Global Hypertension and Heart Failure Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Hypertension and Heart Failure Drugs Market Share by Application in 2018 & 2025
Figure Men Case Studies
Figure Women Case Studies
Figure Hypertension and Heart Failure Drugs Report Years Considered
Figure Global Hypertension and Heart Failure Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Share by Regions 2014-2019
Figure Global Hypertension and Heart Failure Drugs Market Share by Regions 2014-2019
Figure Global Hypertension and Heart Failure Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Hypertension and Heart Failure Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Share by by Players (2014-2019)
Figure Global Hypertension and Heart Failure Drugs Market Share by by Players in 2018
Table Global Hypertension and Heart Failure Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hypertension and Heart Failure Drugs Product/Solution/Service
Table Date of Enter into Hypertension and Heart Failure Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Size Share by Type (2014-2019)
Figure Global Hypertension and Heart Failure Drugs Market Size Market Share by Type (2014-2019)
Table Global Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Hypertension and Heart Failure Drugs Market Size Share by Application (2014-2019)
Figure Global Hypertension and Heart Failure Drugs Market Size Market Share by Application (2014-2019)
Figure Global Hypertension and Heart Failure Drugs Revenue Market Share by Application in 2018
Figure North America Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table North America Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table North America Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure Europe Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table Europe Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table Europe Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure China Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table China Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table China Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table China Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table China Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure Japan Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table Japan Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table Japan Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure Southeast Asia Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table Southeast Asia Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table Southeast Asia Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure India Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table India Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table India Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table India Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table India Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Figure Central & South America Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
Table Central & South America Hypertension and Heart Failure Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Hypertension and Heart Failure Drugs Market Share by Type 2014-2019
Table Central & South America Hypertension and Heart Failure Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Hypertension and Heart Failure Drugs Market Share by Application 2014-2019
Table Menarini Group Company Details
Table Menarini Group Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Menarini Group Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Lupin Company Details
Table Lupin Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Lupin Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Lupin Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Novartis Company Details
Table Novartis Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Novartis Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Merck & Co Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer, Inc Company Details
Table Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Pfizer, Inc Recent Development
Table Sanofi SA Company Details
Table Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Sanofi SA Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business 2014-2019 (Million US$)
Figure Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
Table Dr. Reddy's Laboratories Recent Development
Table Daiichi Sankyo Company Limited Company Details
Table Global Hypertension and Heart Failure Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Hypertension and Heart Failure Drugs Market Size Share by Regions (2019-2025)
Figure Global Hypertension and Heart Failure Drugs Market Size Share by Regions in 2025
Figure North America Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Hypertension and Heart Failure Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Hypertension and Heart Failure Drugs Market Size by Product (2019-2025)
Figure Global Hypertension and Heart Failure Drugs Market Size by Product in 2025
Table Global Hypertension and Heart Failure Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Hypertension and Heart Failure Drugs Market Size by Application (2019-2025)
Figure Global Hypertension and Heart Failure Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Menarini Group、Johnson & Johnson、Lupin、Boehringer Ingelheim、Novartis、Merck & Co、AstraZeneca、Pfizer, Inc、Sanofi SA、Dr. Reddy's Laboratories、Daiichi Sankyo Company Limited

★調査レポート[高血圧および心不全薬の世界市場:規模・現状・予測2019-2025] (コード:DATA910T06615)販売に関する免責事項を必ずご確認ください。
★調査レポート[高血圧および心不全薬の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆